HALOZYME THERAPEUTICS, INC. — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
144
25
3
3/A
4
4/A
424A
424B3
424B5
5
8-A12B
8-A12B/A
8-A12G
8-K
8-K/A
ARS
CERTAMX
CERTNAS
CORRESP
CT ORDER
DEF 14A
DEFA14A
DEFM14C
EFFECT
NT 10-Q
POS AM
PRE 14A
PREM14C
REGDEX
S-3
S-3ASR
S-8
S-8 POS
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-T
SC TO-T/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | — | 0001415889-25-004509 | Feb 18, 2025 | Feb 15, 2025 |
| 4 | — | 0001415889-25-004506 | Feb 18, 2025 | Feb 15, 2025 |
| 4 | — | 0001415889-25-004243 | Feb 14, 2025 | Feb 12, 2025 |
| 4 | — | 0001415889-25-004234 | Feb 14, 2025 | Feb 12, 2025 |
| 4 | — | 0001415889-25-004237 | Feb 14, 2025 | Feb 12, 2025 |
| 4 | — | 0001415889-25-004240 | Feb 14, 2025 | Feb 12, 2025 |
| 8-K | 8-K | 0001159036-25-000005 | Feb 13, 2025 | Feb 11, 2025 |
| 4 | — | 0001415889-25-003006 | Feb 4, 2025 | Feb 3, 2025 |
| 144 | — | 0001950047-25-000583 | Feb 3, 2025 | — |
| 8-K | 8-K | 0001159036-25-000003 | Jan 8, 2025 | — |
| 4 | — | 0001415889-25-000995 | Jan 7, 2025 | Jan 6, 2025 |
| 144 | — | 0001950047-25-000143 | Jan 6, 2025 | — |
| 4 | — | 0001415889-25-000811 | Jan 6, 2025 | Jan 3, 2025 |
| 4 | — | 0001415889-24-028062 | Dec 3, 2024 | Nov 29, 2024 |
| 4 | — | 0001415889-24-028058 | Dec 3, 2024 | Nov 29, 2024 |
| SC 13G/A | SC 13G/A | 0001193125-24-255297 | Nov 12, 2024 | — |
| 8-K | 8-K | 0001159036-24-000049 | Oct 31, 2024 | — |
| 10-Q | 10-Q | 0001159036-24-000050 | Oct 31, 2024 | Sep 30, 2024 |
| 144 | — | 0001950047-24-007759 | Oct 16, 2024 | — |
| 4 | — | 0001415889-24-025233 | Oct 16, 2024 | Oct 15, 2024 |
| 144 | — | 0001950047-24-007745 | Oct 15, 2024 | — |
| 4 | — | 0001415889-24-024936 | Oct 9, 2024 | Oct 8, 2024 |
| 144 | — | 0001950047-24-007636 | Oct 9, 2024 | — |
| 144 | — | 0001950047-24-007614 | Oct 8, 2024 | — |
| 144 | — | 0001950047-24-007401 | Sep 26, 2024 | — |
| 4 | — | 0001415889-24-024001 | Sep 26, 2024 | Sep 24, 2024 |
| 144 | — | 0001950047-24-007380 | Sep 25, 2024 | — |
| 144 | — | 0001950047-24-007362 | Sep 24, 2024 | — |
| 4 | — | 0001415889-24-023657 | Sep 18, 2024 | Sep 17, 2024 |
| 144 | — | 0001950047-24-007204 | Sep 18, 2024 | — |
| 144 | — | 0001950047-24-007164 | Sep 17, 2024 | — |
| 144 | — | 0001950047-24-006981 | Sep 12, 2024 | — |
| 4 | — | 0001415889-24-023307 | Sep 12, 2024 | Sep 10, 2024 |
| 144 | — | 0001950047-24-006949 | Sep 11, 2024 | — |
| 144 | — | 0001950047-24-006923 | Sep 10, 2024 | — |
| 4 | — | 0001415889-24-022363 | Aug 27, 2024 | — |
| 4 | — | 0001415889-24-021850 | Aug 21, 2024 | Aug 20, 2024 |
| 144 | — | 0001950047-24-006333 | Aug 21, 2024 | — |
| 144 | — | 0001950047-24-006258 | Aug 20, 2024 | — |
| 144 | — | 0001950047-24-006096 | Aug 15, 2024 | — |
| 4 | — | 0001415889-24-021370 | Aug 15, 2024 | Aug 13, 2024 |
| 4 | — | 0001415889-24-021305 | Aug 14, 2024 | Aug 12, 2024 |
| 144 | — | 0001950047-24-006001 | Aug 14, 2024 | — |
| 144 | — | 0001950047-24-005968 | Aug 13, 2024 | — |
| 144 | — | 0002031215-24-000001 | Aug 7, 2024 | — |
| 8-K | 8-K | 0001159036-24-000043 | Aug 6, 2024 | — |
| 10-Q | 10-Q | 0001159036-24-000044 | Aug 6, 2024 | Jun 30, 2024 |
| 144 | — | 0001950047-24-005575 | Jul 24, 2024 | — |
| 4 | — | 0001415889-24-020055 | Jul 24, 2024 | Jul 23, 2024 |
| 144 | — | 0001950047-24-005562 | Jul 23, 2024 | — |